Under construction – not a live service
Sign in
CompletedNo phase

Frequen-ZZZ SleepPad Investigational Device POC

Key facts

Who runs it
Kunasan Inc.
Where
State College, United StatesSee the site
Trial code
Status
Completed
People taking part
10 people enrolled
Started
21 Jul 2023
Ended
10 May 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Activated Sleep Pad system (Frequen-ZZZ)
  • Deactivated Sleep Pad system (Frequen-ZZZ)
Record updated
16 December 2024

Who can take part

Age
40 years to 65 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Written informed consent is obtained from the subject
  • Subject is an English speaker and reader. They are able to understand the procedures related to the study
  • Subject is 40-65 years of age at enrollment (by self report at Screening \& verified with photo ID at full Consent)
  • Subject is not engaged in rotating or nocturnal shift employment (by self-report at Screening)
  • Subject is living independently (by self-report and/or according to their status at a community living facility)
  • Subject's personal residence is equipped with functional WiFi and subject is willing to permit study device connection to their WiFi (by self-report at Screening)
  • Insomnia Severity Index score of ≥8 at enrollment (based on self-administration at screening)
  • Willing to refrain from initiating new, sleep-directed interventions (e.g. medication; behavioral) that are not a part of this study protocol for the duration of study participation (by self-report)
  • Willing to refrain from all nicotine use for the duration of participation (by self-report)
  • Willing to refrain from pet access to the bed or sleeping space for the duration of participation (by self-report)
  • Regularly sleeping on a non-water bed (by self-report)
  • Has and uses own smart phone or tablet device, and is willing to continue to use personal device daily for study purposes (by self-report)

Who cannot take part

  • Taking any physician-directed pharmacologic intervention for sleep or actively engaged in a clinically-validated course of therapy (including behavioral therapy for sleep; by self-report)
  • Diagnosed hydration problems or taking prescribed diuretic medication (by self-report)
  • Was previously engaged in this research as a randomized participant
  • Diagnosed with a sleep disorder (by self-report)
  • Diagnosed serious mental/neurologic health disorder or substance use disorder (e.g., autism, psychosis, depression/bipolar, dementia; by self-report)
  • Personal health history of epilepsy or traumatic brain injury (by self-report)
  • History of negative reaction to acupuncture (by self-report)
  • History of sensitivity to, or considers oneself to be uniquely sensitive to, radio-frequency (by self-report)
  • Has an implanted medical device (e.g., pacemaker, cochlear; by self-report)
  • Pregnant, breast-feeding, or planning to become pregnant during the study participation period (by self-report)
  • Recreational use of illicit substances in the past month (by self-report)
  • Any nicotine use in the past 3 months (by self-report)
  • If a participant does not live within a reasonable commutable distance from the Penn State University - University Park campus (i.e. ~20min) to accommodate off-site study visits, then they must be willing to accept the costs and responsibilities of coming to campus (15-17 visits) in order to participate

Where in United States

  • The Pennsylvania State UniversityState College, United StatesNo longer taking part

About the trial

What the trial wants to find out

The investigators propose to examine the potential effects of the Frequen- ZZZ sleep pad - a noninvasive, unobtrusive appliance that generates a localized low-level electromagnetic field via radiofrequency, and that is used on the bed - on multiple sleep outcomes in an 8-week randomized crossover study, and to calculate the effect sizes of the intervention to inform power and sample size for future studies.

The 2 groups in the trial

  • Activated Sleep Pad controllerTreatment being tested

    Treatment dosing is under participant control, by physical proximity/orientation to the Sleep Pad pad portion of the Sleep Pad system, and by a manually operated power button on an activated bedside controller portion of the Sleep Pad system. Dosing is pre-set at a stable level across all participants. Dosing occurs throughout a participant's typical nocturnal sleep period, nightly, unless manually paused by the participant.

    Treatment: Activated Sleep Pad system (Frequen-ZZZ)

  • Deactivated Sleep Pad controllerSham treatment, for comparison

    Use of the Sleep Pad system is consistent with the Experimental arm, excepting that a deactivated bedside controller portion of the Sleep Pad system is used.

    Treatment: Deactivated Sleep Pad system (Frequen-ZZZ)

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Use of the Frequen-ZZZ Sleep Pad to Increase Restorative Sleep: A Proof-of-Concept Study
Record updated
16 December 2024